infusion of the ang ii receptor antagonist saralasin into the mesenteric artery at doses between 0.05 and 0.1 microgram.kg-1.min-1 attenuated the reduction in renal blood flow produced by intrarenal injection of ang ii .
C0036193
saralasin
C0003009
ang ii